Literature DB >> 17539238

IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria.

Nada Pitabut1, Jarinee Panichakorn, Yuvadee Mahakunkijcharoen, Chakrit Hirunpetcharat, Sornchai Looareesuwan, Srisin Khusmith.   

Abstract

Naturally acquired immune response to C-terminal region of Plasmodium vivax merozoite surface protein1 (PvMSP1) in 200 individuals with recent clinical episodes of malaria from malaria endemic areas along Thai-Myanmar border in the west and Thai-Cambodia border in the east of Thailand was evaluated by enzyme-linked immunosorbent assay (ELISA). The anti-PvMSP1-IgG antibody was observed in 110 individuals (55%). Among IgG responders, IgG1 coexpressed with IgG3 were the predominant subclasses. The levels of anti-PvMSP1 total IgG, IgG1 and IgG3 antibody response seem to be increased with age although no detectable significant correlation was found (r = 0.004, p = 0.484 for total IgG; r = 0.035, p = 0.386 for IgG1; r = -0.600, p = 0.142 for IgG2; r = 0.077, p = 0.227 for IgG3; r = 0.664, p = 0.051 for IgG4). However, the mean level of specific total IgG was highest in the age group of >40 years. These levels of either specific total IgG or each IgG isotype did not vary among individuals with different malaria episodes. A higher level of specific total IgG, IgG1 and IgG3 antibody response related with the lower of parasitemia density was observed although no significant correlation was found. Our data indicate that individuals exposed to vivax malaria in Thailand developed antibodies to the potential candidate vaccine antigen, PvMSP1 (C-terminal).

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17539238

Source DB:  PubMed          Journal:  Southeast Asian J Trop Med Public Health        ISSN: 0125-1562            Impact factor:   0.267


  5 in total

1.  Evaluation of the naturally acquired antibody immune response to the Pv200L N-terminal fragment of Plasmodium vivax merozoite surface protein-1 in four areas of the Amazon Region of Brazil.

Authors:  Luciane M Storti-Melo; Wanessa C Souza-Neiras; Gustavo C Cassiano; Leonardo C Taveira; Antônio J Cordeiro; Vanja S C A Couto; Marinete M Póvoa; Maristela G Cunha; Diana M Echeverry; Andréa R B Rossit; Myriam Arévalo-Herrera; Sócrates Herrera; Ricardo L D Machado
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

2.  Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates.

Authors:  Jung-Mi Kang; Hye-Lim Ju; Yoo-Mi Kang; Dong-Hyun Lee; Sung-Ung Moon; Woon-Mok Sohn; Jae-Won Park; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2012-06-18       Impact factor: 2.979

3.  Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand.

Authors:  Rhea J Longley; Camila T França; Michael T White; Chalermpon Kumpitak; Patiwat Sa-Angchai; Jakub Gruszczyk; Jessica B Hostetler; Anjali Yadava; Christopher L King; Rick M Fairhurst; Julian C Rayner; Wai-Hong Tham; Wang Nguitragool; Jetsumon Sattabongkot; Ivo Mueller
Journal:  Malar J       Date:  2017-04-28       Impact factor: 2.979

4.  Naturally Acquired Antibody Responses to Plasmodium vivax and Plasmodium falciparum Merozoite Surface Protein 1 (MSP1) C-Terminal 19 kDa Domains in an Area of Unstable Malaria Transmission in Southeast Asia.

Authors:  Qinghui Wang; Zhenjun Zhao; Xuexing Zhang; Xuelian Li; Min Zhu; Peipei Li; Zhaoqing Yang; Ying Wang; Guiyun Yan; Hong Shang; Yaming Cao; Qi Fan; Liwang Cui
Journal:  PLoS One       Date:  2016-03-21       Impact factor: 3.240

5.  Naturally-Acquired Immune Response against Plasmodium vivax Rhoptry-Associated Membrane Antigen.

Authors:  Siriruk Changrob; Bo Wang; Jin-Hee Han; Seong-Kyun Lee; Myat Htut Nyunt; Chae Seung Lim; Takafumi Tsuboi; Patchanee Chootong; Eun-Taek Han
Journal:  PLoS One       Date:  2016-02-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.